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Background: Juvenile amyotrophic lateral sclerosis (jALS) is a rare form of ALS with
an onset age of less than 25 years and is frequently thought to be genetic in origin.
DDHD1 gene mutations have been reported to be associated with the SPG28 subtype
of autosomal recessive HSP but have never been reported in jALS patients.
Methods: Gene screens for the causative genes of ALS, HSP and CMT using
next-generation sequencing (NGS) technologies were performed on a jALS patient.
Sanger sequencing was used to validate identified variants and perform segregation
analysis.
Results: We identified a novel c.1483A>G (p.Met495Val) homozygous missense
mutation of the DDHD1 gene in the jALS patient. All of his parents and young bother
were heterozygous for this mutation. The mutation was not found in 800 Chinese control
subjects or the database of dbSNP, ExAC and 1000G.
Conclusion: The novel c.1483A>G (p.Met495Val) missense mutation of the DDHD1
gene could be a causative mutation of autosomal recessive jALS.
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INTRODUCTION
Juvenile amyotrophic lateral sclerosis (jALS) is a rare form of ALS with an onset age of less than 25
years and is thought to more frequently have a genetic origin than the adult-onset forms. Juvenile
ALS is a clinically and genetically heterogeneous disease. Mutations in ALS2, SETX and SPG11
are known to cause familial jALS with slow disease progression (Orban et al., 2007). In recent
literatures, SIGMAR1 have been reported to be a new causative gene of autosomal recessive jALS
(Al-Saif et al., 2011; Ullah et al., 2015). However, in sporadic juvenile ALS patients, mutations in
Fus are the most frequent genetic cause (Hübers et al., 2015; Zou et al., 2016). On the contrary to
slow progression in familial jALS, sporadic jALS patients with FUS or SOD1mutations experienced
aggressive progression and short survival times (Zou et al., 2016). Some of jALS causative genes
have also been reported in other diseases, such as ALS2 and SPG11 causing hereditary spastic
paraplegia (HSP) as well (Eymard-Pierre et al., 2002; Klebe et al., 2015). In this report, we describe
a jALS patient with a novel missense mutation in the DDHD1 gene, which is a member of
the intracellular phospholipase A1 gene family and involved in the regulation of mitochondrial
function. Associations have been reported between mutations in the DDHD1 gene and the SPG28
subtype of autosomal recessive HSP but have never been reported in jALS patients.
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MATERIALS AND METHODS
Subjects
The pedigree for the family is presented in the Figure 1A. The
clinical characteristics of the patient will be discussed in results
section.
Ethics Statement
The institutional ethics committee of Peking University Third
Hospital approved this study (IRB00006761). Written, informed
consent was obtained from each participant.
Genetic Analysis
We obtained blood sample from affected and unaffected subjects
in the pedigree (III-7, III-8, IV-1, IV-2). Next generation
FIGURE 1 | Family pedigree and genomic sequence electropherograms. (A) Family pedigree. The jALS patient was born to consanguineous Chinese parents.
All of his parents and young brother were healthy. Males and Females are represented as squares and circles, respectively. The filled symbol represents the affected
patient while unaffected individuals are represented by clear symbols. Crossed circles or squares represent deceased individuals. A double line indicates
consanguineous mating. (B) Genomic sequence electropherograms. The jALS patient carried a novel homozygous c.1483A>G (p.Met495Val) missense mutation of
the DDHD1 gene, which was not detected in 800 healthy unrelated Chinese individuals. All of his parents and young brother were heterozygous for this mutation.
Pedigree analysis suggested that the disease is consistent with autosomal recessive inheritance.
sequencing (NGS)was performed on an Illumina GAIIx platform
to screen for variations in the patient, which covers the
coding exons and flanking intronic sequences of 190 causative
genes of ALS, HSP, and Charcot-Marie-Tooth disease (CMT)
(Supplementary file). Identified variants in NGS were validated
by Sanger sequencing. In order to perform segregation analysis,
all of the patients’ parents and young brother were screened for
the identified variants using Sanger sequencing.
RESULTS
Clinical Features
The patient (IV-1) was a 24-year-old male who developed
walking difficulties due to leg weakness beginning at 16 years
of age and exhibited atrophy of the bilateral first interosseous
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muscles accompanied by a mild weakness in the hands 1
year later. These symptoms have progressed slowly. Besides,
he didn’t complain of any sensory abnormality. He was born
to consanguineous Chinese parents. His parents and younger
brother were clinically healthy. All of them didn’t present any
weakness or atrophy of muscle.
Neurologic examinations were performed for the patient (IV-
1), his parents (III-7, III-8) and young brother (IV-2). In the
patient, examinations revealed a steppage gait, atrophy of the
bilateral interosseous and thenar muscles with a split-hand sign,
mild weakness in the hands and lower limbs, hyperreflexia in
all limbs with positive bilateral Babinski signs and Hoffmann
signs, and disappearance of abdominal reflexes. Sensation and
coordination were normal. As for the patients’ parents and young
brother, neurological examinations showed no muscle atrophy,
normal tendon reflex and negative pathological reflex.
Needle EMG was performed on the patient. The results
showed neurogenic changes, including fibrillation potentials
and positive sharp waves, in four regions (brainstem, cervical,
thoracic, and lumbosacral spinal cord). Nerve conduction
studies revealed decreases in the amplitude of compound motor
and sensory action potentials with an almost normal nerve
conduction velocity. The structure brain and cervical MRIs were
normal. Upon 1H-MRS examination, no pathological lactate
accumulation was found in the cerebrospinal fluid of lateral
ventricles.
Genetic Results
Gene screens for the causative genes of ALS, HSP, and CMT using
NGS technologies identified a novel homozygous c.1483A>G
(p.Met495Val)(RefSeq NM_001160147.1) missense mutation of
the DDHD1 gene in the patient (Figure 1B), which was verified
by Sanger sequencing. Meanwhile, Sanger sequencing revealed
all of his parents and young brother were heterozygous for
this mutation (Figure 1B). The mutation was not detected in
800 healthy unrelated Chinese individuals by whole exome
sequencing or NGS.
DISCUSSION
DDHD1, also known as SPG28 or PA-PLA1, is a member of
the intracellular phospholipase A1 gene family. The protein
encoded by the DDHD1 gene is a cytosolic protein with some
mitochondrial localization and is involved in the regulation
of mitochondrial dynamics via phosphatidic acid (PA) (Baba
et al., 2014). The PA on the surface of mitochondria is
known to regulate mitochondrial fusion. DDHD1 is the first
identified intracellular phospholipase A1 and preferentially
hydrolyzes PA in vitro. The DDHD1 pathogenic mutations
cause reduced PA-PLA1 activity, and the resultant increased
PA content on the surface of mitochondria might cause the
impairment of mitochondrial fusion and lead to the dysfunction
of mitochondria (Tesson et al., 2012). The previous study
has showed the ectopic expression of DDHD1 in HeLa cells
induced mitochondrial fragmentation, whereas its depletion
caused mitochondrial elongation. Gene disruption of DDHD1
in mice caused sperm malformation due to mitochondrial
organization defects (Baba et al., 2014). In patients harboring
pathogenic DDHD1 gene mutations, histochemical analyses
in muscle showed mitochondrial alterations, and multiple
mitochondrial DNA (mtDNA) deletions were evident (Mignarri
et al., 2016). Besides, mitochondrial respiration rate, total cellular
and mitochondrial ATP content were found to be significantly
lower in lymphoblast from SPG28 patients (Tesson et al., 2012).
In brain 1H-MRS analysis, a mild pathological accumulation of
lactate in the cerebrospinal fluid was detected in a SPG28 patient
with 20 years of disease duration, (Liguori et al., 2014) but not
other three patients with shorter disease duration.(Liguori et al.,
2014; Mignarri et al., 2016)
In previous studies, 8 mutations of the DDHD1 gene have
been reported in autosomal recessive HSP patients, including
three nonsense mutations, three frame-shift mutations and two
mutations affecting the mRNA splicing site (Tesson et al., 2012;
Liguori et al., 2014; Mignarri et al., 2016; Miura et al., 2016). All
of these mutations predict changes in the protein translation of
the DDHD domain, which is responsible for the phospholipase
activity of the DDHD1 protein, thereby leading to a loss of
function in the protein and finally mitochondrial dysfunction.
In our report, the patient carried a novel homozygous
c.1483A>G (p.Met495Val) missense mutation located in exon
7 of the DDHD1 gene (Figure 2). His parents and younger
brother were heterozygous for this mutation. Pedigree analysis
suggested that the disease is consistent with autosomal recessive
inheritance. The mutation was not detected in 800 healthy
unrelated Chinese individuals, suggesting that the mutation is
not present in the normal Chinese population.
Furthermore, this new mutation, located in a conserved
domain (Figure 3), was not found in dbSNP, ExAC or
1000G database and was predicted to be disease causing by
MutationTaster, possibly damaging by Polyphen-2 and affecting
protein function by SIFT. So we concluded this variant was a
pathogenic mutation rather than a polymorphism.
Mitochondrial dysfunction is one of the important
pathophysiological mechanisms in ALS (Mancuso and Navarro,
2015). In our report, the novel homozygous missense DDHD1
mutation might cause jALS via mitochondrial dysfunction.
Unlike the previously reported mutations, the new mutation
may not change the protein primary structure but rather the
three-dimensional structure of the DDHD domain, ultimately
causing a loss of function in the protein. However, further
functional studies are needed to confirm mitochondrial
dysfunction in ALS patients with DDHD1 gene mutations.
Patients with DDHD1 gene mutations have presented pure
or mildly complicated HSP in previous studies (Bouslam et al.,
2005; Tesson et al., 2012; Liguori et al., 2014; Mignarri et al., 2016;
Miura et al., 2016). Tongue fasciculation with wasting have been
reported previously, (Liguori et al., 2014) indicating thatDDHD1
gene mutations may influence lower motor neuron (LMN)
function. In this patient, muscle atrophy of hands with a split-
hand sign was apparent, and needle EMG confirmed neurogenic
damage in four regions. We believe that the decreased amplitude
of compound motor action potentials was the result of severe
LMNdamage. Apart frommotor system involvement, subclinical
sensory axonal neuropathy was detected in this patient. In
previous reports, clinical and subclinical sensory defects had
been reported in HSP patients with DDHD1 gene mutations,
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FIGURE 2 | Schematic representation of DDHD1 on chromosome 14
and DDHD1 protein. (A) Schematic representation of DDHD1 on
chromosome 14 (RefSeq NM_001160147.1). The black boxes represent
coding exons. The upper row shows the novel missense mutation c.1483A>G
(p.Met495Val) in our report, and the lower row shows the mutations in previous
reports.c.1249C>T, c.1766G>A, c.1874delT, c.2438-1G>T (RefSeq
NM_030637.2) (Tesson et al., 2012). c.1422_1423insA, c.2279delT (RefSeq
NM_030637.2) (Liguori et al., 2014). c.1429C>T (RefSeq NM_001160148)
(Mignarri et al., 2016). c.914_917delGTAA (RefSeq NM_030637.2) (Miura
et al., 2016). (B) Schematic representation of DDHD1 protein (RefSeq
NP_001153619.1). The red box represents DDHD domain in the C-terminus.
The upper row shows the novel p.M495V mutation identified in this study. The
known mutations are indicated below. p.R417*, p.R589Q, p.L625*,
c.2438-1G>T(p.?)(RefSeq NP_085140.2) (Tesson et al., 2012). p.V476Sfs*20,
p.M760Sfs*37 (RefSeq NP_085140.2) (Liguori et al., 2014). p.R477* (RefSeq
NP_001153620.1) (Mignarri et al., 2016). p.S305Ifs*2 (RefSeq NP_085140.2)
(Miura et al., 2016).
which reflected DDHD1 gene mutations might cause sensory
defects (Bouslam et al., 2005; Liguori et al., 2014). Moreover,
subclinical sensory abnormalities, peripheral as well as central
levels, could be found in ALS patients who didn’t have other
known potential causes of polyneuropathy, such as diabetes
mellitus (Pugdahl et al., 2007; Iglesias et al., 2015; Isak et al.,
2016). A multicenter study reported 22.7% patients with ALS had
sensory nerve action potentials (SNAPs) abnormalities in at least
one nerve (Pugdahl et al., 2007). Although pathophysiological
mechanisms underlying sensory abnormalities remains to be
further clarified, these findings reflected that ALS might be a
multi-systemic disorder involving other systems than motor. In
the revision of the EI Escorial criteria 2015, sensory impairment
does not exclude ALS diagnosis. Besides, UMN and LMN
impairment, rather than subclinical sensory impairment, was the
dominant presentation in this patient. Finally, the patient was
diagnosed with lab-supported probable jALS. Considering the
clinical history of this patient and previously reported cases, we
believe that jALS patients with DDHD1 mutations could have
slow disease progression, similar to that of other familial jALS
patients.
FIGURE 3 | Conservation of the amino acid affected by the missense
mutation. Amino acid sequence alignments around the single amino acid
affected by the novel DDHD1 gene mutation are shown for selected species.
The amino acid affected by the novel p.Met495Val missense mutation is
highlighted by a red rectangle. This novel mutation was located in a very
conserved domain, and was predicted to be disease causing by
MutationTaster, possibly damaging by Polyphen-2 and affecting protein
function by SIFT.
In summary, this is the first case report about the relationship
between DDHD1 gene mutations and jALS. Besides of dominant
motor system involvement, subclinical sensory impairment was
detected in this jALS patient. All of these findings reflected
the clinically and genetically heterogeneity of jALS and further
proved the genetic overlap between HSP and jALS. Meanwhile,
further functional studies are needed to confirm the effects of
DDHD1 gene mutations in ALS pathogenesis.
CONCLUSION
Juvenile ALS is a clinically and genetically heterogeneous disease.
As described in our report, we discovered a novel c.1483A>G
(p.Met495Val) missense mutation of theDDHD1 gene that could
be a causative mutation of autosomal recessive jALS.
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